FDA Issues Vytorin Early Communication
FDA Reviews Vytorin. The Food & Drug Administration (FDA) weighed in on the Vytorin controversy today by issuing an Early Communication about its ongoing reviews of Vytorin, Zetia and Zocor. The FDA communication was prompted by preliminary results of the ENHANCE study that showed Vytorin was no better at preventing plaque … [Read more...]
FDA Reviews Boston Scientific Acid Reflux Device After Death
Death After Treated with a Boston Scientific Corp. Acid Reflux Device. The Food and Drug Administration is reviewing the death last month of an elderly woman after she was treated with a Boston Scientific Corp. device for acid reflux disease. The FDA is also looking at injuries in six other patients treated with the Enteryx … [Read more...]
